{"id":"NCT00528970","sponsor":"Bausch Health Americas, Inc.","briefTitle":"A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus After Ventral Hernia Repair","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10-17","primaryCompletion":"2008-02-05","completion":"2008-02-05","firstPosted":"2007-09-14","resultsPosted":"2019-09-04","lastUpdate":"2019-09-04"},"enrollment":374,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ileus"],"interventions":[{"type":"DRUG","name":"MOA-728","otherNames":["Methylnaltrexone"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"MOA-728 12 mg","type":"EXPERIMENTAL"},{"label":"MOA-728 24 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \\[mg\\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of bowel function in participants receiving opioid analgesia administered via patient-controlled anesthesia (PCA), and who had undergone repair of large (greater than or equal to \\[â‰¥\\]10 centimeters) ventral hernias with or without a mesh prosthesis via laparotomy or laparoscopy.","primaryOutcome":{"measure":"Time to First Bowel Movement","timeFrame":"Day 1 (From the time of end of surgery [that is; from the first dose of study drug administration]) up to Day 10","effectByArm":[{"arm":"MOA-728 12 mg","deltaMin":93.3,"sd":3.2},{"arm":"MOA-728 24 mg","deltaMin":100.4,"sd":4.2},{"arm":"Placebo","deltaMin":91.3,"sd":3.9}],"pValues":[{"comp":"OG000 vs OG002","p":"0.944"},{"comp":"OG001 vs OG002","p":"0.208"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":106,"countries":["United States","Australia","Belgium","Canada","Germany","Hungary","Italy","Netherlands","Poland","South Africa","South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":124},"commonTop":["Nausea","Vomiting","Pyrexia","Pruritus","Constipation"]}}